Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Updated: Pfizer to further decrease stake in consumer health company Haleon
8 months ago
Lilly-partnered radiopharma startup Aktis Oncology raises $175M
8 months ago
Financing
Startups
For some multiple myeloma patients, Carvykti cut risk of death by 45%
8 months ago
R&D
Cell/Gene Tx
US government renews threats over J&J's proposed 340B rebate model
8 months ago
FDA+
Law
Novo Nordisk to decrease some insulin pen manufacturing, transition supply
8 months ago
Manufacturing
FDA approves Dupixent in COPD, opening ‘next chapter’ for Sanofi and Regeneron’s bestseller
8 months ago
FDA+
Cassava and its former execs settle SEC charges for ‘misleading’ Alzheimer’s drug data
8 months ago
Law
FDA approves Bristol Myers and Karuna's schizophrenia drug, in milestone for psychiatry
8 months ago
FDA+
FDA lifts hold on Biomea’s diabetes trials
8 months ago
FDA+
AstraZeneca's lung cancer blockbuster Tagrisso wins label expansion in early-stage EGFR patients
8 months ago
FDA+
Genentech's Gazyva hits primary endpoint in late-stage kidney disease trial
8 months ago
R&D
Updated: FDA adcomm votes to limit Opdivo, Keytruda use in stomach, esophageal cancers based on key biomarker
8 months ago
FDA+
Pfizer pulls sickle cell drug from all markets after data review showed rise in deaths and complications
8 months ago
FDA+
UK watchdog criticizes Moderna for Covid-19 trial's use of WhatsApp to dangle payments to children
8 months ago
Marketing
EMA to discuss Pfizer's sickle cell drug Oxbryta after patient deaths
8 months ago
FDA+
Baltimore sues Biogen, saying the company colluded with PBMs to minimize generic competition
8 months ago
Law
Emergent says it has $400M in orders related to mpox outbreak
8 months ago
Manufacturing
FDA OKs IntraBio's drug less than a week after rare disease's first-ever approval
8 months ago
FDA+
2seventy bio, Bristol Myers stop late-stage Abecma study in multiple myeloma due to recruitment challenges
8 months ago
R&D
Novo Nordisk CEO skeptical of PBM promises in Senate hearing on weight loss drug prices
8 months ago
FDA+
SIGA fires former NYC Covid advisor after secret recordings detail pandemic-era parties
8 months ago
People
Federal judge rules against Regeneron's attempt to halt Amgen from launching Eylea biosimilar
8 months ago
Law
Sanofi hires Mike Quigley as next chief scientist, internal memo says
8 months ago
People
J&J subsidiary files for third bankruptcy to settle talc claims
8 months ago
Law
First page
Previous page
34
35
36
37
38
39
40
Next page
Last page